119 related articles for article (PubMed ID: 38402088)
21. Application of CT radiomics features to predict the EGFR mutation status and therapeutic sensitivity to TKIs of advanced lung adenocarcinoma.
Yang C; Chen W; Gong G; Li Z; Qiu Q; Yin Y
Transl Cancer Res; 2020 Nov; 9(11):6683-6690. PubMed ID: 35117278
[TBL] [Abstract][Full Text] [Related]
22. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
[TBL] [Abstract][Full Text] [Related]
23. MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain.
Wu C; Zheng H; Li J; Zhang Y; Duan S; Li Y; Wang D
Eur Radiol; 2022 Mar; 32(3):1813-1822. PubMed ID: 34655310
[TBL] [Abstract][Full Text] [Related]
24. Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis.
Kim M; Suh CH; Lee SM; Park JE; Kim HC; Kim SO; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
AJR Am J Roentgenol; 2021 Nov; 217(5):1184-1193. PubMed ID: 34037408
[No Abstract] [Full Text] [Related]
25. Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels.
Niu S; Zhang H; Wang X; Jiang W
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):643-649. PubMed ID: 37380152
[TBL] [Abstract][Full Text] [Related]
26. Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation.
Cheng B; Deng H; Zhao Y; Xiong J; Liang P; Li C; Liang H; Shi J; Li J; Xiong S; Lai T; Chen Z; Wu J; Qian T; Huan W; Ng MTA; He J; Liang W
Eur Radiol; 2022 Sep; 32(9):5869-5879. PubMed ID: 35348863
[TBL] [Abstract][Full Text] [Related]
27. Predicting
Zhang G; Cao Y; Zhang J; Ren J; Zhao Z; Zhang X; Li S; Deng L; Zhou J
Am J Cancer Res; 2021; 11(2):546-560. PubMed ID: 33575086
[TBL] [Abstract][Full Text] [Related]
28. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
[TBL] [Abstract][Full Text] [Related]
29. Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery.
Jiang Z; Wang B; Han X; Zhao P; Gao M; Zhang Y; Wei P; Lan C; Liu Y; Li D
Eur Radiol; 2022 Apr; 32(4):2266-2276. PubMed ID: 34978579
[TBL] [Abstract][Full Text] [Related]
30. Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma.
Hong D; Xu K; Zhang L; Wan X; Guo Y
Front Oncol; 2020; 10():28. PubMed ID: 32082997
[No Abstract] [Full Text] [Related]
31. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
[TBL] [Abstract][Full Text] [Related]
32. Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC.
Cheng Y; Wang H; Yuan W; Wang H; Zhu Y; Chen H; Jiang W
Phys Med; 2023 Dec; 116():103177. PubMed ID: 38000098
[TBL] [Abstract][Full Text] [Related]
33. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
[TBL] [Abstract][Full Text] [Related]
34. Radiomics nomogram integrating intratumoural and peritumoural features to predict lymph node metastasis and prognosis in clinical stage IA non-small cell lung cancer: a two-centre study.
Chen QL; Li MM; Xue T; Peng H; Shi J; Li YY; Duan SF; Feng F
Clin Radiol; 2023 May; 78(5):e359-e367. PubMed ID: 36858926
[TBL] [Abstract][Full Text] [Related]
35. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
Sang L; Liu Z; Huang C; Xu J; Wang H
Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
[TBL] [Abstract][Full Text] [Related]
36. Optimal
Zuo Y; Liu Q; Li N; Li P; Zhang J; Song S
Front Oncol; 2023; 13():1173355. PubMed ID: 37223682
[TBL] [Abstract][Full Text] [Related]
37. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
[TBL] [Abstract][Full Text] [Related]
38. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
[No Abstract] [Full Text] [Related]
39. Combination of
Li S; Li Y; Zhao M; Wang P; Xin J
Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
[TBL] [Abstract][Full Text] [Related]
40. The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram.
Wang S; Chen Y; Zhang H; Liang Z; Bu J
Front Oncol; 2021; 11():707686. PubMed ID: 34722254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
